Abstract Title:

Molecular mechanisms of melatonin's inhibitory actions on breast cancers.

Abstract Source:

Cell Mol Life Sci. 2012 Sep 25. Epub 2012 Sep 25. PMID: 23007844

Abstract Author(s):

Sara Proietti, Alessandra Cucina, Russel J Reiter, Mariano Bizzarri

Article Affiliation:

Department of Clinical and Molecular Medicine, University"La Sapienza", Rome, Italy.

Abstract:

Melatonin is involved in many physiological functions and it plays an important role in many pathological processes as well. Melatonin has been shown to reduce the incidence of experimentally induced cancers and can significantly inhibit the growth of some human tumors, namely hormone-dependent cancers. The anticancer effects of melatonin have been observed in breast cancer, both in in vivo with models of chemically induced rat mammary tumors, and in vitro studies on human breast cancer cell lines. Melatonin acts at different physiological levels and its antitumoral properties are supported by a set of complex, different mechanisms of action, involving apoptosis activation, inhibition of proliferation, and cell differentiation.

Study Type : In Vitro Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.